Fosun comes to Lucerne

The Chinese company Fosun Pharma has founded a subsidiary in Lucerne. As reported by the Handelszeitung, Fosun Pharmaceutical AG has one million Swiss francs in share capital. The choice of location was actively supported by Lucerne Business.

Mr. Chen Qiyu
Mr. Chen Qiyu, Co-President of Fosun Group and Chairman of Fosun Pharma (Image Credit: Fosun Group)

Fosun International is a family-focused multinational company that has been listed on the main board of the Hong Kong Stock Exchange (00656:HK) since 2007. Founded in 1992, Fosun's total assets exceed RMB500 billion (US$75 billion). With its roots in China, and through technology and innovation, Fosun’s mission is to create customer-to-maker (C2M) ecosystems in health, happiness and wealth, providing high-quality products and services for families around the world.

The choice of location of the Fosun subsidiary was supported by the Lucerne Economic Development authorities

“We actively supported the steps needed to found the company,” said Rouven Willimann, head of Promotion and Settlement at Lucerne Business. “Every new references helps us put Lucerne on the world map.”

Willimann also pointed out that the Chinese company Porton Pharmaceutical Chemicals opened an office in 2013 in Horw in the canton of Lucerne. The company is growing and plans to concentrate its entire European presence in Horw.

Recommend us
How should we contact you?

Premium Partner

Strategic partners

Institutional partner

Official program